These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 9631148

  • 21. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V, ANRS 1201/1202 DITRAME PLUS Study Group.
    AIDS; 2005 Feb 18; 19(3):309-18. PubMed ID: 15718842
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD, Holtgrave DR, Pinkerton HJ.
    Arch Intern Med; 1997 Sep 22; 157(17):1972-80. PubMed ID: 9308509
    [Abstract] [Full Text] [Related]

  • 23. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM, Tsevat J.
    Med Decis Making; 2004 Sep 22; 24(1):30-9. PubMed ID: 15005952
    [Abstract] [Full Text] [Related]

  • 24. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
    Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, Bénifla JL, Burgard M, Lachassine E, Barret B, Chaix ML, Bongain A, Ciraru-Vigneron N, Crenn-Hébert C, Delfraissy JF, Rouzioux C, Mayaux MJ, Blanche S, Agence Nationale de Recherches sur le SIDA (ANRS) 075 Study Group.
    JAMA; 2001 Apr 25; 285(16):2083-93. PubMed ID: 11311097
    [Abstract] [Full Text] [Related]

  • 25. The mother-to-child HIV transmission debate.
    Beyers N, Cotton MF, Donald PR, Gie RP, Henning PA, Hesseling PB, Kirsten GF, Kling S, Nel ED, Pieper CH, Ravenscroft A, Schaaf HS, Schoeman JF, Smith J, van Buuren AJ, van der Merwe PL, van Schalkwyk HJ, Wessels G.
    S Afr Med J; 1999 Feb 25; 89(2):104, 106. PubMed ID: 10357681
    [No Abstract] [Full Text] [Related]

  • 26. The mother-to-child HIV transmission debate.
    Hussey G, Fransman D, McGillivray G, Reynolds L, Jacobs M, Power D, Burgess J, Eley B, Woods D, Coetzee N, Coetzee E, Anthony J, Maartens G, Schaaf S, Cotton M, Theron G.
    S Afr Med J; 1999 Feb 25; 89(2):103-4. PubMed ID: 10191847
    [No Abstract] [Full Text] [Related]

  • 27. Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis.
    Stringer JS, Rouse DJ.
    Obstet Gynecol; 1999 Jul 25; 94(1):34-40. PubMed ID: 10389714
    [Abstract] [Full Text] [Related]

  • 28. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
    Bhana N, Ormrod D, Perry CM, Figgitt DP.
    Paediatr Drugs; 2002 Jul 25; 4(8):515-53. PubMed ID: 12126455
    [Abstract] [Full Text] [Related]

  • 29. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
    Thaineua V, Sirinirund P, Tanbanjong A, Lallemant M, Soucat A, Lamboray JL.
    Southeast Asian J Trop Med Public Health; 1998 Sep 25; 29(3):429-42. PubMed ID: 10437936
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1.
    Halpern MT, Read JS, Ganoczy DA, Harris DR.
    AIDS; 2000 Apr 14; 14(6):691-700. PubMed ID: 10807192
    [Abstract] [Full Text] [Related]

  • 33. A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US.
    Lacey L, Mauskopf J, Lindrooth R, Pham S, Saag M, Sawyer W.
    Pharmacoeconomics; 1999 Apr 14; 15 Suppl 1():23-37. PubMed ID: 10537440
    [Abstract] [Full Text] [Related]

  • 34. Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines.
    Phillips AN, Bansi-Matharu L, Venter F, Havlir D, Pozniak A, Kuritzkes DR, Wensing A, Lundgren JD, Pillay D, Mellors J, Cambiano V, Jahn A, Apollo T, Mugurungi O, Ripin D, Da Silva J, Raizes E, Ford N, Siberry GK, Gupta RK, Barnabas R, Revill P, Cohn J, Calmy A, Bertagnolio S.
    Lancet HIV; 2020 Mar 14; 7(3):e193-e200. PubMed ID: 32035041
    [Abstract] [Full Text] [Related]

  • 35. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
    Giraudon I, Leroy V, Msellati P, Elenga N, Ramon R, Welffens-Ekra C, Dabis F.
    Sante; 1999 Mar 14; 9(5):277-81. PubMed ID: 10657769
    [Abstract] [Full Text] [Related]

  • 36. Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa.
    Ngambi PG, Kalungia AC, Law MR, Kalemeera F, Truter I, Godman B, Munkombwe D.
    Expert Rev Pharmacoecon Outcomes Res; 2017 Oct 14; 17(5):459-467. PubMed ID: 28770641
    [Abstract] [Full Text] [Related]

  • 37. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
    Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F.
    Lancet; 2003 Sep 13; 362(9387):859-68. PubMed ID: 13678973
    [Abstract] [Full Text] [Related]

  • 38. The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB.
    Ann N Y Acad Sci; 2000 Nov 13; 918():53-6. PubMed ID: 11131734
    [No Abstract] [Full Text] [Related]

  • 39. The mother-to-child HIV transmission debate.
    Joubert JR, Beale MW.
    S Afr Med J; 1999 Feb 13; 89(2):106. PubMed ID: 10191849
    [No Abstract] [Full Text] [Related]

  • 40. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N, Poolsup N, Ket-Aim S.
    J Clin Pharm Ther; 2007 Jun 13; 32(3):293-311. PubMed ID: 17489882
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.